The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2019 | The role of surgery in the immuno-oncology era
Eric Lim, MD, of the Royal Brompton & Harefield NHS Foundation Trust, London, UK, discusses the updates in thoracic oncology surgery from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland. Prof. Lim explains how there is now a focus on investigating the optimal method of combining immuno-oncology agents and surgery, and expresses his excitement at an upcoming trial looking at surgery vs. no surgery after immunotherapy for advanced lung cancer.
